Article(id=1325224545161969935, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325224446230934140, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2026.02.011, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1753632000000, receivedDateStr=2025-07-28, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793887753047, onlineDateStr=2026-11-05, pubDate=1770652800000, pubDateStr=2026-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793887753047, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793887753047, creator=13701087609, updateTime=1793887753047, updator=13701087609, issue=Issue{id=1325224446230934140, tenantId=1146029695717560320, journalId=1319690329412173987, year='2026', volume='47', issue='2', pageStart='107', pageEnd='212', issueExtLink='null', onlineDate='null', pubDate='1770652800000', pubDateStr='2026-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793887729460, creator='13701087609', updateTime=1793934840172, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325422043109400703, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325224446230934140, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325422043109400704, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325224446230934140, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=184, endPage=197, ext={EN=ArticleExt(id=1325224545363296528, articleId=1325224545161969935, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Meta-analysis of novel oral factor Ⅹa inhibitors in the treatment of pulmonary embolism in middle-aged and elderly patients, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=
Objective

To systematically evaluate the clinical efficacy and safety of novel oral factor Ⅹa inhibitors(such as rivaroxaban, apixaban, edoxaban, etc.) in the treatment of middle-aged and elderly patients with pulmonary embolism, to provide evidence-based references for the clinical application of such drugs.

Methods

The databases of CNKI, Wanfang Data, VIP, PubMed, Cochrane Library, Web of Science, and Embase were searched by computer to collect randomized controlled trials(RCTs) on the treatment of pulmonary embolism in middle-aged and elderly patients with novel oral factorⅩa inhibitors. The retrieval time limit for all databases was from the establishment of the databases to December 2024. After two researchers independently screened the literature, extracted the data, and evaluated the bias risks of the included studies, the RevMan 5.4 software was used for meta-analysis.

Results

A total of 28 RCTs were included, involving 73,764 patients. The medications in the experimental group included novel oral factor Ⅹa inhibitors such as rivaroxaban, apixaban, and edoxaban. The results of the meta-analysis showed that, compared with traditional anticoagulant drugs, novel oral factor Ⅹa inhibitors could significantly improve the clinical effective rate[odds ratio(OR)=1.68, 95% confidence interval·(CI): 1.32—2.15, P<0.001], and there was no significant increase in the risk of bleeding (clinically relevant non-major bleeding OR=0.97, 95%CI: 0.78—1.21, P=0.77; minor bleeding OR=1.21, 95%CI: 0.91—1.38, P=0.29).

Conclusion

Current evidence shows that novel oral factor Ⅹa inhibitors have significant clinical efficacy in the treatment of middle-aged and elderly patients with pulmonary embolism, and compared with traditional anticoagulant drugs, they do not significantly increase the risk of bleeding.

, authors=Qinghuan LI1, 2a, Haifeng LI2b, Ling ZHANG2a, Jiali ZHU1, Zonglu LI3, Xiaona TONG2a, *, authorsList=Qinghuan LI, Haifeng LI, Ling ZHANG, Jiali ZHU, Zonglu LI, Xiaona TONG, authorCompany=null, correspAuthors=Xiaona TONG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325224545606566161, articleId=1325224545161969935, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=新型口服Ⅹa因子抑制剂治疗中老年肺栓塞的meta分析, columnId=1325221089235841093, journalTitle=世界临床药物, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=
目的

系统评价新型口服Ⅹa因子抑制剂(如利伐沙班、阿哌沙班及艾多沙班等)治疗中老年肺栓塞患者的有效性及安全性,为该类药物的临床应用提供循证参考。

方法

计算机检索知网、万方、维普、PubMed、Cochrane Library、Web of Science及Embase数据库,搜集关于新型口服Ⅹa因子抑制剂治疗中老年肺栓塞的随机对照试验,检索时限均为建库至2024年12月,由2名研究者独立筛选文献、提取资料并评价纳入研究的偏倚风险后,采用RevMan 5.4软件进行meta分析。

结果

共纳入28项随机对照试验,涉及73 764例患者,试验组用药包括利伐沙班、阿哌沙班及艾多沙班等。结果显示,与传统抗凝药物相比,新型口服Ⅹa因子抑制剂能显著提高临床有效率[比值比(odds ratio,OR)=1.68,95%置信区间(confidence interval,CI):1.32~2.15,P<0.001],且出血风险无显著增加(临床相关的非大出血OR=0.97,95%CI:0.78~1.21,P=0.77;小出血OR=1.21,95%CI:0.91~1.38,P=0.29)。

结论

当前证据显示,新型口服Ⅹa因子抑制剂治疗中老年肺栓塞患者具有显著的临床疗效,且与传统抗凝药物相比,未显著增加出血风险。

, authors=李晴欢1, 2a, 李海峰2b, 张玲2a, 朱家丽1, 李宗露3, 佟晓娜2a, *, authorsList=李晴欢, 李海峰, 张玲, 朱家丽, 李宗露, 佟晓娜, authorCompany=null, correspAuthors=佟晓娜, authorNote=

李晴欢,硕士研究生,研究方向:临床药学。

, correspAuthorsNote=
佟晓娜,副主任药师,研究方向:临床药学,呼吸系统疾病。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=4Ss2AzGZoIjSSZdBpk9Ktg==, magXml=5EIP9lXiJiY0j1YeQO8G0A==, pdfUrl=null, pdf=ZUzWWMWfah9x0z33+5GMPQ==, pdfFileSize=1696101, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=+G22uLY5IZRdyPNZKjbTJA==, mapNumber=null, fund=null)}, authors=[Author(id=1325224548324475167, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325224548534190370, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224548324475167, language=EN, stringName=Qinghuan LI, firstName=Qinghuan, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2a, address=1.College of Pharmacy, Dali University, Dali 671000, Yunnan Province, China
2a.Department of Pharmacy, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224548618076451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224548324475167, language=CN, stringName=李晴欢, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2a, address=1.大理大学药学院,云南 大理 671000
2a.云南省第三人民医院药剂科,云南 昆明 650011, bio={"content":"

李晴欢,硕士研究生,研究方向:临床药学。

"}, bioImg=null, bioContent=

李晴欢,硕士研究生,研究方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224547695329554, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=1., ext=[AuthorCompanyExt(id=1325224547703718163, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547695329554, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Pharmacy, Dali University, Dali 671000, Yunnan Province, China), AuthorCompanyExt(id=1325224547712106772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547695329554, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.大理大学药学院,云南 大理 671000)]), AuthorCompany(id=1325224547787604245, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=2a., ext=[AuthorCompanyExt(id=1325224547795992854, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547787604245, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2a.Department of Pharmacy, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China), AuthorCompanyExt(id=1325224547808575767, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547787604245, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2a.云南省第三人民医院药剂科,云南 昆明 650011)])]), Author(id=1325224548701962533, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325224548777460007, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224548701962533, language=EN, stringName=Haifeng LI, firstName=Haifeng, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2b, address=2b.Department of Respiratory Medicine, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224548848763176, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224548701962533, language=CN, stringName=李海峰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2b, address=2b.云南省第三人民医院呼吸与危重症医学科,云南 昆明 650011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224548085399832, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=2b., ext=[AuthorCompanyExt(id=1325224548093788441, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224548085399832, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2b.Department of Respiratory Medicine, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China), AuthorCompanyExt(id=1325224548110565658, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224548085399832, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2b.云南省第三人民医院呼吸与危重症医学科,云南 昆明 650011)])]), Author(id=1325224548911677738, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325224548995563820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224548911677738, language=EN, stringName=Ling ZHANG, firstName=Ling, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2a, address=2a.Department of Pharmacy, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224549083644205, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224548911677738, language=CN, stringName=张玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2a, address=2a.云南省第三人民医院药剂科,云南 昆明 650011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224547787604245, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=2a., ext=[AuthorCompanyExt(id=1325224547795992854, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547787604245, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2a.Department of Pharmacy, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China), AuthorCompanyExt(id=1325224547808575767, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547787604245, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2a.云南省第三人民医院药剂科,云南 昆明 650011)])]), Author(id=1325224549167530287, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325224549247222065, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224549167530287, language=EN, stringName=Jiali ZHU, firstName=Jiali, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.College of Pharmacy, Dali University, Dali 671000, Yunnan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224549352079666, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224549167530287, language=CN, stringName=朱家丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.大理大学药学院,云南 大理 671000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224547695329554, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=1., ext=[AuthorCompanyExt(id=1325224547703718163, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547695329554, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Pharmacy, Dali University, Dali 671000, Yunnan Province, China), AuthorCompanyExt(id=1325224547712106772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547695329554, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.大理大学药学院,云南 大理 671000)])]), Author(id=1325224549456937268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325224549763121462, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224549456937268, language=EN, stringName=Zonglu LI, firstName=Zonglu, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.College of Dai Medicine, Western Yunnan University of Applied Sciences, Xishuangbanna Yunnan 666199, Yunnan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224549847007543, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224549456937268, language=CN, stringName=李宗露, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.滇西应用技术大学傣医药学院,云南 西双版纳 666199, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224548211228955, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=3., ext=[AuthorCompanyExt(id=1325224548219617564, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224548211228955, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.College of Dai Medicine, Western Yunnan University of Applied Sciences, Xishuangbanna Yunnan 666199, Yunnan Province, China), AuthorCompanyExt(id=1325224548240589085, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224548211228955, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.滇西应用技术大学傣医药学院,云南 西双版纳 666199)])]), Author(id=1325224549918310713, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325224551784775995, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224549918310713, language=EN, stringName=Xiaona TONG, firstName=Xiaona, middleName=null, lastName=TONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2a, *, address=2a.Department of Pharmacy, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224551851884860, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224549918310713, language=CN, stringName=佟晓娜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2a, *, address=2a.云南省第三人民医院药剂科,云南 昆明 650011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224547787604245, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=2a., ext=[AuthorCompanyExt(id=1325224547795992854, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547787604245, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2a.Department of Pharmacy, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China), AuthorCompanyExt(id=1325224547808575767, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547787604245, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2a.云南省第三人民医院药剂科,云南 昆明 650011)])])], keywords=[Keyword(id=1325224551965131069, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, language=EN, orderNo=1, keyword=novel oral factor Ⅹa inhibitors), Keyword(id=1325224552032239934, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, language=EN, orderNo=2, keyword=pulmonary embolism), Keyword(id=1325224552111931711, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, language=EN, orderNo=3, keyword=meta-analysis), Keyword(id=1325224552187429184, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, language=CN, orderNo=1, keyword=新型口服Ⅹa因子抑制剂), Keyword(id=1325224552262926657, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, language=CN, orderNo=2, keyword=肺栓塞), Keyword(id=1325224552338424130, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, language=CN, orderNo=3, keyword=meta分析)], refs=[Reference(id=1325224552569110852, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=KONSTANTINIDES SV, MEYER G, BECATTINI C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society(ERS)[J]. Eur Heart J, 2020, 41(4): 543-603., articleTitle=null, refAbstract=null), Reference(id=1325224552640414021, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=KEARON C, AKL EA, ORNELAS J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report[J]. Chest, 2016, 149(2): 315-352., articleTitle=null, refAbstract=null), Reference(id=1325224552707522886, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=STEFFEL J, COLLINS R, ANTZ M, et al. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation[J]. Europace, 2021, 23(10): 1612-1676., articleTitle=null, refAbstract=null), Reference(id=1325224552787214663, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=van der HULLE T, KOOIMAN J, den EXTER PL, et al. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis[J]. J Thromb Haemost, 2014, 12(3): 320-328., articleTitle=null, refAbstract=null), Reference(id=1325224552871100744, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=SILVERIO A, DI MAIO M, PROTA C, et al. Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 22 studies and 440 281 patients[J]. Eur Heart J Cardiovasc Pharmacother, 2021, 7(FI1): f20-f29., articleTitle=null, refAbstract=null), Reference(id=1325224552942403913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=马春芳, 汤榕, 杨晓花, 等. 基于健康社会决定因素的宁夏中老年人慢性病共病的影响因素研究[J]. 中国全科医学, 2024, 27(4): 447-453., articleTitle=null, refAbstract=null), Reference(id=1325224553005318474, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=于鸿敏, 乔华, 张向宁, 等. 阿哌沙班联合瑞替普酶对急性肺栓塞患者凝血功能与安全性影响[J]. 中国煤炭工业医学杂志, 2021, 24(4): 381-386., articleTitle=null, refAbstract=null), Reference(id=1325224553076621643, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=谢函君, 邵克武. 低分子肝素钙联合利伐沙班治疗老年晚期肺癌合并肺栓塞的效果研究[J]. 实用临床医药杂志, 2020, 24(7): 27-30., articleTitle=null, refAbstract=null), Reference(id=1325224553143730508, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=张敏霞. 低分子肝素钙联合利伐沙班治疗老年急性肺栓塞的临床疗效[J]. 实用心脑肺血管病杂志, 2018, 26(2): 114-118., articleTitle=null, refAbstract=null), Reference(id=1325224553210839373, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=李春艳. 低分子肝素钙与利伐沙班在老年急性肺栓塞治疗中的联合应用[J]. 当代医学, 2020, 26(3): 4-6., articleTitle=null, refAbstract=null), Reference(id=1325224553277948238, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=杨金方, 冯玲, 郑海静. 利伐沙班及低分子肝素治疗老年急性肺栓塞患者的效果及其对血流动力学水平及血管内皮功能的影响[J]. 中国医学工程, 2022, 30(6): 67-70., articleTitle=null, refAbstract=null), Reference(id=1325224553345057103, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=高海燕, 卢鑫, 朱颖, 等. 利伐沙班片对老年肺栓塞患者血清D-D、NT-proBNP水平等影响及临床疗效[J]. 中国老年学杂志, 2022, 42(4): 836-838., articleTitle=null, refAbstract=null), Reference(id=1325224553412165968, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=江刚, 张卫东, 彭敏恋. 利伐沙班在急性中危肺血栓栓塞合并下肢深静脉血栓患者治疗中的临床意义[J]. 中国呼吸与危重监护杂志, 2018, 17(2): 172-177., articleTitle=null, refAbstract=null), Reference(id=1325224553508634961, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=张园, 辛芳妮. 利伐沙班治疗老年肺血栓栓塞症患者的临床效果[J]. 临床医学研究与实践, 2023, 8(23): 41-44., articleTitle=null, refAbstract=null), Reference(id=1325224553584132434, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=BULLER HR, PRINS MH, LENSIN AWA, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism[J]. N Engl J Med, 2012, 366(14): 1287-1297., articleTitle=null, refAbstract=null), Reference(id=1325224553651241299, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=BULLER HR, DECOUSUS H, GROSSO MA, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism[J]. N Engl J Med, 2013, 369(15):1406-1415., articleTitle=null, refAbstract=null), Reference(id=1325224553777070420, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU XC, JOHNSON M, MARDEKIAN J, et al. Apixaban reduces hospitalizations in patients with venous thromboembolism: an analysis of the apixaban for the initial management of pulmonary embolism and deep-vein thrombosis as first-line therapy(AMPLIFY) trial[J]. J Am Heart Assoc, 2015, 4(12): e002340., articleTitle=null, refAbstract=null), Reference(id=1325224553936453973, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=WELLS PS, PRINS MH, LEVITAN B, et al. Long-term anticoagulation with rivaroxaban for preventing recurrent VTE: a benefit-risk analysis of EINSTEIN-extension[J]. Chest, 2016, 150(5): 1059-1068., articleTitle=null, refAbstract=null), Reference(id=1325224554007757142, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=NISIO MD, VEDOVATI MC, RIERA-MESTRE A, et al. Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies[J]. Thromb Haemost, 2016, 116(4): 739-746., articleTitle=null, refAbstract=null), Reference(id=1325224554079060311, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=WEITZ JI, LENSING AWA, PRINS MH, et al. Rivaroxaban or aspirin for extended treatment of venous thromboembolism[J]. N Engl J Med, 2017, 376(13): 1211-1222., articleTitle=null, refAbstract=null), Reference(id=1325224554146169176, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=COHEN AT, AGNELLI G, BULLER HR, et al. Characteristics and outcomes in patients with venous thromboembolism taking concomitant anti-platelet agents and anticoagulants in the AMPLIFY trial[J]. Thromb Haemost, 2019, 119(3): 461-466., articleTitle=null, refAbstract=null), Reference(id=1325224554251026777, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=BREKELMANS MPA, BLEKER SM, BAUERSACHS R, et al. Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists[J]. Thromb Haemost, 2016, 116(1): 155-161., articleTitle=null, refAbstract=null), Reference(id=1325224554326524250, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU XC, THOMPSON J, PHATAK H, et al. Extended anticoagulation with apixaban reduces hospitalisations in patients with venous thromboembolism. an analysis of the AMPLIFY-EXT trial[J]. Thromb Haemost, 2016, 115(1):161-168., articleTitle=null, refAbstract=null), Reference(id=1325224554397827419, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=BREKELMANS MPA, AGENO W, BEENEN LF, et al. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study[J]. Lancet Haematol, 2016, 3(9): e437-e445., articleTitle=null, refAbstract=null), Reference(id=1325224554464936284, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=NISIO MD, RASKOB G, BULLER HR, et al. Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists[J]. Thromb Haemost, 2017, 117(4): 784-793., articleTitle=null, refAbstract=null), Reference(id=1325224554544628061, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=DUAN L, ZHANG N, YAN H, et al. Comparison of rivaroxaban mono-therapy and standard-therapy adjusted by CYP2C9 and VKORC1 genotypes in symptomatic pulmonary embolism[J]. Clin Chim Acta, 2016, 459: 25-29., articleTitle=null, refAbstract=null), Reference(id=1325224554607542622, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=MEDINA A, RASKOB G, AGENO W, et al. Outpatient management in patients with venous thromboembolism with edoxaban: a post hoc analysis of the Hokusai-VTE study[J]. Thromb Haemost, 2017, 117(12): 2406-2414., articleTitle=null, refAbstract=null), Reference(id=1325224556444647775, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=NAKAMURA M, NISHIKAWA M, KOMURO I, et al. Apixaban for the treatment of Japanese subjects with acute venous thromboembolism(AMPLIFY-J Study)[J]. Circ J, 2015, 79(6): 1230-1236., articleTitle=null, refAbstract=null), Reference(id=1325224556524339552, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=PRINS MH, BAMBER L, CANO SJ, et al. Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial[J]. Thromb Res, 2015, 135(2): 281-288., articleTitle=null, refAbstract=null), Reference(id=1325224556595642721, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=YOUNG AM, MARSHALL A, THIRLWALL J, et al. Comparison of an oral factor Ⅹa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial(SELECT-D)[J]. J Clin Oncol, 2018, 36(20): 2017-2023., articleTitle=null, refAbstract=null), Reference(id=1325224556679528802, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=RASKOB GE, NICK EV, PETER V, et al. A randomized, open-label, blinded outcome assessment trial evaluating the efficacy and safety of LMWH/edoxaban versus dalteparin for venous thromboembolism associated with cancer: Hokusai VTE-cancer study[J]. Blood, 2017, doi:10.1182/blood.V130.Suppl_1.LBA-6.LBA-6., articleTitle=null, refAbstract=null), Reference(id=1325224556880855395, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=YOUNG AM, MARSHALL A, THIRLWALL J, et al. Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism: results of the select-D™ pilot trial[J]. Blood, 2017, 130(S1): 625., articleTitle=null, refAbstract=null), Reference(id=1325224556960547172, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=NISIO MD, van Es N, CARRIER M, et al. Extended treatment with edoxaban in cancer patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE cancer study[J]. J Thromb Haemost, 2019, 17(11): 1866-1874., articleTitle=null, refAbstract=null), Reference(id=1325224557023461733, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=RASKOB GE, BULLER H, ANGCHAISUKSIRI P, et al. Edoxaban for long-term treatment of venous thromboembolism in cancer patients[J]. Blood, 2013,122(21): 211., articleTitle=null, refAbstract=null), Reference(id=1325224557077987686, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=中国药学会医院药学专业委员会. 口服抗凝药居家管理中国专家共识(2024版)[J]. 中华医学杂志, 2024, 104(28):2595-2612., articleTitle=null, refAbstract=null)], funds=[Fund(id=1325224552451670339, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, awardId=81860017/H0109, language=CN, fundingSource=国家自然科学基金委员会资助项目(81860017/H0109), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1325224547695329554, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=1., ext=[AuthorCompanyExt(id=1325224547703718163, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547695329554, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Pharmacy, Dali University, Dali 671000, Yunnan Province, China), AuthorCompanyExt(id=1325224547712106772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547695329554, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.大理大学药学院,云南 大理 671000)]), AuthorCompany(id=1325224547787604245, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=2a., ext=[AuthorCompanyExt(id=1325224547795992854, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547787604245, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2a.Department of Pharmacy, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China), AuthorCompanyExt(id=1325224547808575767, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547787604245, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2a.云南省第三人民医院药剂科,云南 昆明 650011)]), AuthorCompany(id=1325224548085399832, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=2b., ext=[AuthorCompanyExt(id=1325224548093788441, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224548085399832, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2b.Department of Respiratory Medicine, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China), AuthorCompanyExt(id=1325224548110565658, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224548085399832, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2b.云南省第三人民医院呼吸与危重症医学科,云南 昆明 650011)]), AuthorCompany(id=1325224548211228955, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=3., ext=[AuthorCompanyExt(id=1325224548219617564, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224548211228955, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.College of Dai Medicine, Western Yunnan University of Applied Sciences, Xishuangbanna Yunnan 666199, Yunnan Province, China), AuthorCompanyExt(id=1325224548240589085, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224548211228955, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.滇西应用技术大学傣医药学院,云南 西双版纳 666199)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.02.011, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.02.011, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2026.02.011, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2026.02.011, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1770652800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
新型口服Ⅹa因子抑制剂治疗中老年肺栓塞的meta分析
李晴欢 1, 2a , 李海峰 2b , 张玲 2a , 朱家丽 1 , 李宗露 3 , 佟晓娜 2a, *
世界临床药物 | 研究论文 2026,47(2): 184-197
收起
收藏切换
世界临床药物 |研究论文 2026 , 47 (2) : 184 -197
新型口服Ⅹa因子抑制剂治疗中老年肺栓塞的meta分析
全屏
[Author(id=1325224548324475167, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325224548534190370, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224548324475167, language=EN, stringName=Qinghuan LI, firstName=Qinghuan, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2a, address=1.College of Pharmacy, Dali University, Dali 671000, Yunnan Province, China
2a.Department of Pharmacy, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224548618076451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224548324475167, language=CN, stringName=李晴欢, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2a, address=1.大理大学药学院,云南 大理 671000
2a.云南省第三人民医院药剂科,云南 昆明 650011, bio={"content":"

李晴欢,硕士研究生,研究方向:临床药学。

"}, bioImg=null, bioContent=

李晴欢,硕士研究生,研究方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224547695329554, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=1., ext=[AuthorCompanyExt(id=1325224547703718163, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547695329554, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Pharmacy, Dali University, Dali 671000, Yunnan Province, China), AuthorCompanyExt(id=1325224547712106772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547695329554, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.大理大学药学院,云南 大理 671000)]), AuthorCompany(id=1325224547787604245, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=2a., ext=[AuthorCompanyExt(id=1325224547795992854, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547787604245, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2a.Department of Pharmacy, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China), AuthorCompanyExt(id=1325224547808575767, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547787604245, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2a.云南省第三人民医院药剂科,云南 昆明 650011)])]), Author(id=1325224548701962533, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325224548777460007, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224548701962533, language=EN, stringName=Haifeng LI, firstName=Haifeng, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2b, address=2b.Department of Respiratory Medicine, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224548848763176, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224548701962533, language=CN, stringName=李海峰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2b, address=2b.云南省第三人民医院呼吸与危重症医学科,云南 昆明 650011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224548085399832, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=2b., ext=[AuthorCompanyExt(id=1325224548093788441, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224548085399832, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2b.Department of Respiratory Medicine, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China), AuthorCompanyExt(id=1325224548110565658, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224548085399832, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2b.云南省第三人民医院呼吸与危重症医学科,云南 昆明 650011)])]), Author(id=1325224548911677738, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325224548995563820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224548911677738, language=EN, stringName=Ling ZHANG, firstName=Ling, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2a, address=2a.Department of Pharmacy, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224549083644205, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224548911677738, language=CN, stringName=张玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2a, address=2a.云南省第三人民医院药剂科,云南 昆明 650011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224547787604245, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=2a., ext=[AuthorCompanyExt(id=1325224547795992854, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547787604245, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2a.Department of Pharmacy, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China), AuthorCompanyExt(id=1325224547808575767, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547787604245, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2a.云南省第三人民医院药剂科,云南 昆明 650011)])]), Author(id=1325224549167530287, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325224549247222065, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224549167530287, language=EN, stringName=Jiali ZHU, firstName=Jiali, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.College of Pharmacy, Dali University, Dali 671000, Yunnan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224549352079666, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224549167530287, language=CN, stringName=朱家丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.大理大学药学院,云南 大理 671000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224547695329554, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=1., ext=[AuthorCompanyExt(id=1325224547703718163, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547695329554, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Pharmacy, Dali University, Dali 671000, Yunnan Province, China), AuthorCompanyExt(id=1325224547712106772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547695329554, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.大理大学药学院,云南 大理 671000)])]), Author(id=1325224549456937268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325224549763121462, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224549456937268, language=EN, stringName=Zonglu LI, firstName=Zonglu, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.College of Dai Medicine, Western Yunnan University of Applied Sciences, Xishuangbanna Yunnan 666199, Yunnan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224549847007543, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224549456937268, language=CN, stringName=李宗露, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.滇西应用技术大学傣医药学院,云南 西双版纳 666199, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224548211228955, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=3., ext=[AuthorCompanyExt(id=1325224548219617564, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224548211228955, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.College of Dai Medicine, Western Yunnan University of Applied Sciences, Xishuangbanna Yunnan 666199, Yunnan Province, China), AuthorCompanyExt(id=1325224548240589085, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224548211228955, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.滇西应用技术大学傣医药学院,云南 西双版纳 666199)])]), Author(id=1325224549918310713, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325224551784775995, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224549918310713, language=EN, stringName=Xiaona TONG, firstName=Xiaona, middleName=null, lastName=TONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2a, *, address=2a.Department of Pharmacy, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224551851884860, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, authorId=1325224549918310713, language=CN, stringName=佟晓娜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2a, *, address=2a.云南省第三人民医院药剂科,云南 昆明 650011, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224547787604245, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, xref=2a., ext=[AuthorCompanyExt(id=1325224547795992854, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547787604245, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2a.Department of Pharmacy, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China), AuthorCompanyExt(id=1325224547808575767, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224545161969935, companyId=1325224547787604245, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2a.云南省第三人民医院药剂科,云南 昆明 650011)])])]
李晴欢1, 2a, 李海峰2b, 张玲2a, 朱家丽1, 李宗露3, 佟晓娜2a, *
作者信息
  • 1.大理大学药学院,云南 大理 671000
  • 2a.云南省第三人民医院药剂科,云南 昆明 650011
  • 2b.云南省第三人民医院呼吸与危重症医学科,云南 昆明 650011
  • 3.滇西应用技术大学傣医药学院,云南 西双版纳 666199
通讯作者:
佟晓娜,副主任药师,研究方向:临床药学,呼吸系统疾病。
作者简介:

李晴欢,硕士研究生,研究方向:临床药学。

Meta-analysis of novel oral factor Ⅹa inhibitors in the treatment of pulmonary embolism in middle-aged and elderly patients
Qinghuan LI1, 2a, Haifeng LI2b, Ling ZHANG2a, Jiali ZHU1, Zonglu LI3, Xiaona TONG2a, *
Affiliations
  • 1.College of Pharmacy, Dali University, Dali 671000, Yunnan Province, China
  • 2a.Department of Pharmacy, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China
  • 2b.Department of Respiratory Medicine, the Third People's Hospital of Yunnan Province, Kunming 650011, Yunnan Province, China
  • 3.College of Dai Medicine, Western Yunnan University of Applied Sciences, Xishuangbanna Yunnan 666199, Yunnan Province, China
出版时间: 2026-02-10 doi: 10.13683/j.wph.2026.02.011
文章导航
收藏切换
目的

系统评价新型口服Ⅹa因子抑制剂(如利伐沙班、阿哌沙班及艾多沙班等)治疗中老年肺栓塞患者的有效性及安全性,为该类药物的临床应用提供循证参考。

方法

计算机检索知网、万方、维普、PubMed、Cochrane Library、Web of Science及Embase数据库,搜集关于新型口服Ⅹa因子抑制剂治疗中老年肺栓塞的随机对照试验,检索时限均为建库至2024年12月,由2名研究者独立筛选文献、提取资料并评价纳入研究的偏倚风险后,采用RevMan 5.4软件进行meta分析。

结果

共纳入28项随机对照试验,涉及73 764例患者,试验组用药包括利伐沙班、阿哌沙班及艾多沙班等。结果显示,与传统抗凝药物相比,新型口服Ⅹa因子抑制剂能显著提高临床有效率[比值比(odds ratio,OR)=1.68,95%置信区间(confidence interval,CI):1.32~2.15,P<0.001],且出血风险无显著增加(临床相关的非大出血OR=0.97,95%CI:0.78~1.21,P=0.77;小出血OR=1.21,95%CI:0.91~1.38,P=0.29)。

结论

当前证据显示,新型口服Ⅹa因子抑制剂治疗中老年肺栓塞患者具有显著的临床疗效,且与传统抗凝药物相比,未显著增加出血风险。

新型口服Ⅹa因子抑制剂  /  肺栓塞  /  meta分析
Objective

To systematically evaluate the clinical efficacy and safety of novel oral factor Ⅹa inhibitors(such as rivaroxaban, apixaban, edoxaban, etc.) in the treatment of middle-aged and elderly patients with pulmonary embolism, to provide evidence-based references for the clinical application of such drugs.

Methods

The databases of CNKI, Wanfang Data, VIP, PubMed, Cochrane Library, Web of Science, and Embase were searched by computer to collect randomized controlled trials(RCTs) on the treatment of pulmonary embolism in middle-aged and elderly patients with novel oral factorⅩa inhibitors. The retrieval time limit for all databases was from the establishment of the databases to December 2024. After two researchers independently screened the literature, extracted the data, and evaluated the bias risks of the included studies, the RevMan 5.4 software was used for meta-analysis.

Results

A total of 28 RCTs were included, involving 73,764 patients. The medications in the experimental group included novel oral factor Ⅹa inhibitors such as rivaroxaban, apixaban, and edoxaban. The results of the meta-analysis showed that, compared with traditional anticoagulant drugs, novel oral factor Ⅹa inhibitors could significantly improve the clinical effective rate[odds ratio(OR)=1.68, 95% confidence interval·(CI): 1.32—2.15, P<0.001], and there was no significant increase in the risk of bleeding (clinically relevant non-major bleeding OR=0.97, 95%CI: 0.78—1.21, P=0.77; minor bleeding OR=1.21, 95%CI: 0.91—1.38, P=0.29).

Conclusion

Current evidence shows that novel oral factor Ⅹa inhibitors have significant clinical efficacy in the treatment of middle-aged and elderly patients with pulmonary embolism, and compared with traditional anticoagulant drugs, they do not significantly increase the risk of bleeding.

novel oral factor Ⅹa inhibitors  /  pulmonary embolism  /  meta-analysis
李晴欢, 李海峰, 张玲, 朱家丽, 李宗露, 佟晓娜. 新型口服Ⅹa因子抑制剂治疗中老年肺栓塞的meta分析. 世界临床药物, 2026 , 47 (2) : 184 -197 . DOI: 10.13683/j.wph.2026.02.011
Qinghuan LI, Haifeng LI, Ling ZHANG, Jiali ZHU, Zonglu LI, Xiaona TONG. Meta-analysis of novel oral factor Ⅹa inhibitors in the treatment of pulmonary embolism in middle-aged and elderly patients[J]. World Clinical Drug, 2026 , 47 (2) : 184 -197 . DOI: 10.13683/j.wph.2026.02.011
  • 国家自然科学基金委员会资助项目(81860017/H0109)
参考文献 引证文献
排序方式:
[1]
KONSTANTINIDES SV, MEYER G, BECATTINI C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society(ERS)[J]. Eur Heart J, 2020, 41(4): 543-603.
[2]
KEARON C, AKL EA, ORNELAS J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report[J]. Chest, 2016, 149(2): 315-352.
[3]
STEFFEL J, COLLINS R, ANTZ M, et al. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation[J]. Europace, 2021, 23(10): 1612-1676.
[4]
van der HULLE T, KOOIMAN J, den EXTER PL, et al. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis[J]. J Thromb Haemost, 2014, 12(3): 320-328.
[5]
SILVERIO A, DI MAIO M, PROTA C, et al. Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 22 studies and 440 281 patients[J]. Eur Heart J Cardiovasc Pharmacother, 2021, 7(FI1): f20-f29.
[6]
马春芳, 汤榕, 杨晓花, 等. 基于健康社会决定因素的宁夏中老年人慢性病共病的影响因素研究[J]. 中国全科医学, 2024, 27(4): 447-453.
[7]
于鸿敏, 乔华, 张向宁, 等. 阿哌沙班联合瑞替普酶对急性肺栓塞患者凝血功能与安全性影响[J]. 中国煤炭工业医学杂志, 2021, 24(4): 381-386.
[8]
谢函君, 邵克武. 低分子肝素钙联合利伐沙班治疗老年晚期肺癌合并肺栓塞的效果研究[J]. 实用临床医药杂志, 2020, 24(7): 27-30.
[9]
张敏霞. 低分子肝素钙联合利伐沙班治疗老年急性肺栓塞的临床疗效[J]. 实用心脑肺血管病杂志, 2018, 26(2): 114-118.
[10]
李春艳. 低分子肝素钙与利伐沙班在老年急性肺栓塞治疗中的联合应用[J]. 当代医学, 2020, 26(3): 4-6.
[11]
杨金方, 冯玲, 郑海静. 利伐沙班及低分子肝素治疗老年急性肺栓塞患者的效果及其对血流动力学水平及血管内皮功能的影响[J]. 中国医学工程, 2022, 30(6): 67-70.
[12]
高海燕, 卢鑫, 朱颖, 等. 利伐沙班片对老年肺栓塞患者血清D-D、NT-proBNP水平等影响及临床疗效[J]. 中国老年学杂志, 2022, 42(4): 836-838.
[13]
江刚, 张卫东, 彭敏恋. 利伐沙班在急性中危肺血栓栓塞合并下肢深静脉血栓患者治疗中的临床意义[J]. 中国呼吸与危重监护杂志, 2018, 17(2): 172-177.
[14]
张园, 辛芳妮. 利伐沙班治疗老年肺血栓栓塞症患者的临床效果[J]. 临床医学研究与实践, 2023, 8(23): 41-44.
[15]
BULLER HR, PRINS MH, LENSIN AWA, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism[J]. N Engl J Med, 2012, 366(14): 1287-1297.
[16]
BULLER HR, DECOUSUS H, GROSSO MA, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism[J]. N Engl J Med, 2013, 369(15):1406-1415.
[17]
LIU XC, JOHNSON M, MARDEKIAN J, et al. Apixaban reduces hospitalizations in patients with venous thromboembolism: an analysis of the apixaban for the initial management of pulmonary embolism and deep-vein thrombosis as first-line therapy(AMPLIFY) trial[J]. J Am Heart Assoc, 2015, 4(12): e002340.
[18]
WELLS PS, PRINS MH, LEVITAN B, et al. Long-term anticoagulation with rivaroxaban for preventing recurrent VTE: a benefit-risk analysis of EINSTEIN-extension[J]. Chest, 2016, 150(5): 1059-1068.
[19]
NISIO MD, VEDOVATI MC, RIERA-MESTRE A, et al. Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies[J]. Thromb Haemost, 2016, 116(4): 739-746.
[20]
WEITZ JI, LENSING AWA, PRINS MH, et al. Rivaroxaban or aspirin for extended treatment of venous thromboembolism[J]. N Engl J Med, 2017, 376(13): 1211-1222.
[21]
COHEN AT, AGNELLI G, BULLER HR, et al. Characteristics and outcomes in patients with venous thromboembolism taking concomitant anti-platelet agents and anticoagulants in the AMPLIFY trial[J]. Thromb Haemost, 2019, 119(3): 461-466.
[22]
BREKELMANS MPA, BLEKER SM, BAUERSACHS R, et al. Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists[J]. Thromb Haemost, 2016, 116(1): 155-161.
[23]
LIU XC, THOMPSON J, PHATAK H, et al. Extended anticoagulation with apixaban reduces hospitalisations in patients with venous thromboembolism. an analysis of the AMPLIFY-EXT trial[J]. Thromb Haemost, 2016, 115(1):161-168.
[24]
BREKELMANS MPA, AGENO W, BEENEN LF, et al. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study[J]. Lancet Haematol, 2016, 3(9): e437-e445.
[25]
NISIO MD, RASKOB G, BULLER HR, et al. Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists[J]. Thromb Haemost, 2017, 117(4): 784-793.
[26]
DUAN L, ZHANG N, YAN H, et al. Comparison of rivaroxaban mono-therapy and standard-therapy adjusted by CYP2C9 and VKORC1 genotypes in symptomatic pulmonary embolism[J]. Clin Chim Acta, 2016, 459: 25-29.
[27]
MEDINA A, RASKOB G, AGENO W, et al. Outpatient management in patients with venous thromboembolism with edoxaban: a post hoc analysis of the Hokusai-VTE study[J]. Thromb Haemost, 2017, 117(12): 2406-2414.
[28]
NAKAMURA M, NISHIKAWA M, KOMURO I, et al. Apixaban for the treatment of Japanese subjects with acute venous thromboembolism(AMPLIFY-J Study)[J]. Circ J, 2015, 79(6): 1230-1236.
[29]
PRINS MH, BAMBER L, CANO SJ, et al. Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial[J]. Thromb Res, 2015, 135(2): 281-288.
[30]
YOUNG AM, MARSHALL A, THIRLWALL J, et al. Comparison of an oral factor Ⅹa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial(SELECT-D)[J]. J Clin Oncol, 2018, 36(20): 2017-2023.
[31]
RASKOB GE, NICK EV, PETER V, et al. A randomized, open-label, blinded outcome assessment trial evaluating the efficacy and safety of LMWH/edoxaban versus dalteparin for venous thromboembolism associated with cancer: Hokusai VTE-cancer study[J]. Blood, 2017, doi:10.1182/blood.V130.Suppl_1.LBA-6.LBA-6.
[32]
YOUNG AM, MARSHALL A, THIRLWALL J, et al. Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism: results of the select-D™ pilot trial[J]. Blood, 2017, 130(S1): 625.
[33]
NISIO MD, van Es N, CARRIER M, et al. Extended treatment with edoxaban in cancer patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE cancer study[J]. J Thromb Haemost, 2019, 17(11): 1866-1874.
[34]
RASKOB GE, BULLER H, ANGCHAISUKSIRI P, et al. Edoxaban for long-term treatment of venous thromboembolism in cancer patients[J]. Blood, 2013,122(21): 211.
[35]
中国药学会医院药学专业委员会. 口服抗凝药居家管理中国专家共识(2024版)[J]. 中华医学杂志, 2024, 104(28):2595-2612.
2026年第47卷第2期
59
13
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2026.02.011
  • 接收时间:2025-07-28
  • 首发时间:2026-11-05
  • 出版时间:2026-02-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-07-28
基金
国家自然科学基金委员会资助项目(81860017/H0109)
作者信息
    1.大理大学药学院,云南 大理 671000
    2a.云南省第三人民医院药剂科,云南 昆明 650011
    2b.云南省第三人民医院呼吸与危重症医学科,云南 昆明 650011
    3.滇西应用技术大学傣医药学院,云南 西双版纳 666199

通讯作者:

佟晓娜,副主任药师,研究方向:临床药学,呼吸系统疾病。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.02.011
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏